The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo.
Oncotarget
; 10(29): 2824-2834, 2019 Apr 19.
Article
in En
| MEDLINE
| ID: mdl-31073373
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Oncotarget
Year:
2019
Document type:
Article
Affiliation country:
United States
Country of publication:
United States